Navigation Links
U.S. Preventive Medicine(R) Awards Inaugural Global Prevention Prize to Dr. Valentin Fuster of Mount Sinai Heart
Date:11/7/2008

ard designed to recognize those whose tireless efforts are making prevention a priority in overcoming global health care concerns," stated Christopher Fey, Chairman and CEO of U.S. Preventive Medicine. "Cardiovascular disease is the number one killer throughout the world. In the United States alone, the cost of treating cardiovascular disease doubled from approximately $150 billion a decade ago to about $300 billion in 2005. This trend will continue unless and until aggressive action is taken to prevent heart disease and promote healthy living. Prevention projects overseen by Dr. Fuster are making significant strides in educating and modifying behaviors in Africa, Colombia, Grenada, Spain, and the United States."

The first annual National Health Science Summit serves as a critical forum for 250 world-leading scientists, top journalists, health policy experts and executives to discuss trends in drug discovery and innovation, healthcare policy and legislation, and explore the frontiers of science, the breakthrough therapies and the implications for global health. Additional awards were presented by notable guests, including former NBA star Earvin "Magic" Johnson.

About Dr. Valentin Fuster

Dr. Fuster is Director of Mount Sinai Heart, Director of the Zena and Michael A. Wiener Cardiovascular Institute, and the Marie-Josee and Henry R. Kravis Center for Cardiovascular Health. He is also the Richard Gorlin, MD/Heart Research Foundation Professor at the Mount Sinai Medical Center and President of Science of the Centor Nacional de Investigaciones Cardiovacalures Carlos III (CNIC) in Madrid. He is a past president of the American Heart Association and the World Heart Federation. Under Dr. Fuster's leadership, Mount Sinai Heart is shaping a new paradigm in cardiovascular care in which clinicians are focused on treating and preventing disease, and promoting optimal heart health around the world.

About U.S. Preventive Medicine

U.S. Preventive
'/>"/>

SOURCE U.S. Preventive Medicine
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. U.S. Preventive Medicine(R) Appoints Glenn Robinette Executive Vice President - Customer Service
2. HealthFitness Launches New Preventive Health Solution for Small Employers
3. New program to help physicians understand role of DNA-based preventive medicine
4. U.S. Preventive Medicine Says Prevention Can Keep Diabetes Costs From Rising
5. U.S. Preventive Medicine(R) Announces Major Development for The Prevention Plan(TM)
6. Research Shows Consumer-Directed Health Plans Encourage Preventive Care
7. U.S. Preventive Medicine(R) to Preview The Prevention Plan(TM) at National Conference for Health Care Technology Innovators
8. U.S. Preventive Medicine(R) Tees Up with Amateur Golf Association
9. Presidential Debate Over Health Care Costs Highlights Need for Preventive Health Care
10. U.S. Preventive Medicine Announces Nationwide Launch of The Prevention Plan
11. U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Cambodia 3A World AIDS Day HIV Campaign Testing Millions to Again Launch During Cambodias National Water Festival 60453 1Cambodia 3A World AIDS Day HIV Campaign Testing Millions to Again Launch During Cambodias National Water Festival 60453 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3